News Focus
News Focus
Followers 4
Posts 1330
Boards Moderated 0
Alias Born 01/01/2007

Re: None

Tuesday, 01/11/2011 9:02:05 AM

Tuesday, January 11, 2011 9:02:05 AM

Post# of 57700
Here's an interesting tidbit:

A company dedicated to facilitating the due dilligence for pharmaceutical partnerships has a newly-testimonial from none other than... Mark Varney:

"ShareVault's focus on speed helps us accelerate the due diligence process. Some of our clinical trial results documents contain thousands of pages, yet our users can open them instantly from ShareVault.".
– Mark Varney
CEO
Cortex Pharmaceuticals

In my morbid obsession with this misbegotten company, I often do searches for anything on the net pertaining to cortex pharmaceuticals that has appeared in the last 24 hours, so I know this is new.

The fact that ShareVault is posting his testimonial means that corx is using the service, and strongly suggests that a splashy deal is imminent. Otherwise, it doesn't make much sense for ShareVault to be trumpeting a penny stock.

Here's the link:
http://www.pandesa.com/solutions/pharmalicensing.htm

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today